drugset / Trial / NCT02552459

Effect of Dexmedetomidine Combined With Sufentanil for Postoperative Intravenous Analgesia in Neurosurgery

NCT02552459

RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to determine effect of combined medication of sufentanil and dexmedetomidine in patient controlled analgesia after neurosurgery.

Timeline

Start
2015-09
Primary completion
2016-12
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.05 ug/kg Intravenous
Subject Dexmedetomidine Other / unclassified 0.1 ug/kg Intravenous
Subject Dexmedetomidine Other / unclassified 0.15 ug/kg Intravenous
Background Sufentanil Other / unclassified 150 ug Intravenous